Related Experiment Video
Updated: Apr 20, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Retrospective analysis of liver cirrhosis influence on heart walls thickness
Jakub Wroński1, Piotr Fiedor2, Monika Kwolczak3
1Students Scientific Group at Department of Pathology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warszawa, Poland; Students Scientific Group at Department of General and Transplantation Surgery, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warszawa, Poland.
Insights
Liver cirrhosis can cause heart wall changes, including left ventricular thickening and right ventricular thinning. These cardiac alterations are linked to increased cardiocirculatory failure deaths in patients without hypertension.
Area of Science:
- Cardiology
- Pathology
- Hepatology
Background:
- Cirrhotic cardiomyopathy is a known cardiac dysfunction in liver cirrhosis patients.
- While impaired cardiac function is common, anatomical myocardial changes are also observed.
- This study focuses on cirrhotic patients without a history of hypertension.
Purpose of the Study:
- To investigate the impact of liver cirrhosis on heart wall thickness.
- To analyze pathological changes in the myocardium of cirrhotic individuals.
- To correlate cardiac anatomical changes with clinical outcomes and causes of death.
Main Methods:
- Retrospective analysis of 11,860 autopsy protocols from 1981-2002.
- Statistical analysis of heart wall thickness in patients with and without hypertension.
- Identification of specific myocardial changes: left ventricular thickening, right ventricular thinning.
Main Results:
- Liver cirrhosis was present in 6.7% of autopsy cases; hypertension was excluded in 697 patients.
- Pathological heart wall changes occurred in 53.2% of cirrhotic patients.
- Left ventricular thickening (9.3%), right ventricular thinning (31.0%), and both (12.9%) were observed. Cardiocirculatory failure was a significant cause of death, especially with left ventricular thickening.
Conclusions:
- Liver cirrhosis can induce significant heart wall thickness changes, including left ventricular hypertrophy and right ventricular thinning.
- Selective left ventricular thickening is associated with a higher incidence of cardiac-related mortality.
- Management of cirrhotic cardiomyopathy necessitates integrated cardiological and hepatological care, particularly for patients with left ventricular hypertrophy.
Objective:
Cirrhotic cardiomyopathy is a chronic cardiac dysfunction in patients with liver cirrhosis. It is mostly characterized by impaired cardiac function, but some myocardial anatomical changes have also been described. The aim of this study was to assess the influence of liver cirrhosis on heart wall thickness changes in a retrospective pathological analysis of cirrhotic patients without hypertension.
Materials And Methods:
Statistical analysis of 11,860 autopsy protocols drawn up between 1981 and 2002 in the Department of Pathology Medical University of Warsaw was done.
Results:
Liver cirrhosis was confirmed by autopsy in 802 patients (6.7%); in 697 patients, hypertension was excluded. Analysis of heart wall thickness showed pathological changes in 53.2% of patients - left ventricular thickening in 9.3%, right ventricular thinning in 31.0%, and both in 12.9%. In clinical assessment, the cause of death in 25.8% of patients was cardiocirculatory failure, significantly more in the group with selective left ventricular thickening. It was the most common cause of death among them. Vascular changes in the upper gastrointestinal tract, liver enlargement and hepatic coma were also significantly related to the heart wall thickness changes occurrence.
Conclusions:
Based on statistical analysis of autopsy material, we concluded that liver cirrhosis can lead to heart wall thickness changes (left ventricular thickening and/or right ventricular thinning). We revealed that patients with selective left ventricular thickening had significantly more cardiac related causes of death. In clinical practice, treatment of cirrhotic cardiomyopathy requires specialized diagnostics and appropriate cardiological procedures involving the participation of a hepatologist, especially in the group of patients with selective left ventricular hypertrophy.
More Related Videos
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction

